Dapagliflozin in the Prevention of Post-Coronary Angioplasty Acute Kidney Injury

NCT05435235 · clinicaltrials.gov ↗

PHASE4

Phase

SUSPENDED

Status

250

Enrollment

OTHER

Sponsor class

Stopped Laboratory UNGAL

Conditions

Acute Kidney Injury
Percutaneous Coronary Intervention

Interventions

DRUG: Dapagliflozin 10mg Tab

Sponsor

Albert Einstein Healthcare Network